251 related articles for article (PubMed ID: 31419843)
41. CD163
Omilian AR; Cannioto R; Mendicino L; Stein L; Bshara W; Qin B; Bandera EV; Zeinomar N; Abrams SI; Hong CC; Yao S; Khoury T; Ambrosone CB
Breast Cancer Res; 2024 May; 26(1):75. PubMed ID: 38720366
[TBL] [Abstract][Full Text] [Related]
42. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
Abd Allah MYY; Fahmi MW; El-Ashwah S
J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
[TBL] [Abstract][Full Text] [Related]
43. Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma.
Azambuja D; Natkunam Y; Biasoli I; Lossos IS; Anderson MW; Morais JC; Spector N
Ann Oncol; 2012 Mar; 23(3):736-742. PubMed ID: 21602260
[TBL] [Abstract][Full Text] [Related]
44. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
[TBL] [Abstract][Full Text] [Related]
45. High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.
Sugimura K; Miyata H; Tanaka K; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
J Surg Oncol; 2015 May; 111(6):752-9. PubMed ID: 25752960
[TBL] [Abstract][Full Text] [Related]
46. Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group.
Wada N; Zaki MA; Hori Y; Hashimoto K; Tsukaguchi M; Tatsumi Y; Ishikawa J; Tominaga N; Sakoda H; Take H; Tsudo M; Kuwayama M; Morii E; Aozasa K;
Histopathology; 2012 Jan; 60(2):313-9. PubMed ID: 22211289
[TBL] [Abstract][Full Text] [Related]
47. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
[TBL] [Abstract][Full Text] [Related]
48. Inverse role of distinct subsets and distribution of macrophage in lung cancer prognosis: a meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Chen G; Shen G; Huang J; Chai Y
Oncotarget; 2016 Jun; 7(26):40451-40460. PubMed ID: 27248173
[TBL] [Abstract][Full Text] [Related]
49. The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis.
Lin M; Ma S; Sun L; Qin Z
Front Oncol; 2022; 12():1094400. PubMed ID: 36741724
[TBL] [Abstract][Full Text] [Related]
50. High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.
Panico L; Tenneriello V; Ronconi F; Lepore M; Cantore N; Dell'Angelo AC; Ferbo L; Ferrara F
Leuk Lymphoma; 2015 Jun; 56(6):1636-42. PubMed ID: 25098425
[TBL] [Abstract][Full Text] [Related]
51. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
[TBL] [Abstract][Full Text] [Related]
52. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis.
Yang Z; Zhang M; Peng R; Liu J; Wang F; Li Y; Zhao Q; Liu J
Int J Colorectal Dis; 2020 Sep; 35(9):1651-1661. PubMed ID: 32666290
[TBL] [Abstract][Full Text] [Related]
53. CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.
Yang L; Wang F; Wang L; Huang L; Wang J; Zhang B; Zhang Y
Oncotarget; 2015 Apr; 6(12):10592-603. PubMed ID: 25871392
[TBL] [Abstract][Full Text] [Related]
54. CD68- and CD163-positive tumor-associated macrophages in triple negative cancer of the breast.
Jamiyan T; Kuroda H; Yamaguchi R; Abe A; Hayashi M
Virchows Arch; 2020 Dec; 477(6):767-775. PubMed ID: 32607685
[TBL] [Abstract][Full Text] [Related]
55. Inferior survival and frequent hepatic dysfunction in non-Hodgkin's lymphoma patients with HBV infection: a systematic review and meta-analysis.
Zhang MY; Gao F; Zhao YW; Ni BW; Huang HH; Hou J
Hematology; 2022 Dec; 27(1):70-79. PubMed ID: 34957924
[TBL] [Abstract][Full Text] [Related]
56. Polarized CD163+ tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer.
Park JY; Sung JY; Lee J; Park YK; Kim YW; Kim GY; Won KY; Lim SJ
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):357-365. PubMed ID: 26508473
[TBL] [Abstract][Full Text] [Related]
57. Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients.
Yi B; Cheng Y; Chang R; Zhou W; Tang H; Gao Y; Zhang C
Biosci Rep; 2023 Feb; 43(2):. PubMed ID: 36633963
[TBL] [Abstract][Full Text] [Related]
58. Prognostic roles of tumor associated macrophages in bladder cancer: a system review and meta-analysis.
Wu SQ; Xu R; Li XF; Zhao XK; Qian BZ
Oncotarget; 2018 May; 9(38):25294-25303. PubMed ID: 29861872
[TBL] [Abstract][Full Text] [Related]
59. The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.
Koh YW; Kang HJ; Park C; Yoon DH; Kim S; Suh C; Go H; Kim JE; Kim CW; Huh J
Oncologist; 2012; 17(6):871-80. PubMed ID: 22588324
[TBL] [Abstract][Full Text] [Related]
60. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
